Literature DB >> 16052543

Reversible self-association increases the viscosity of a concentrated monoclonal antibody in aqueous solution.

Jun Liu1, Mary D H Nguyen, James D Andya, Steven J Shire.   

Abstract

This study was conducted to investigate the effect of reversible protein self-association on the viscosity of concentrated monoclonal antibody solutions. The viscosities of the monoclonal antibody solutions were measured by either a capillary viscometer or a cone-plate rheometer at different protein concentrations, pH, and ionic strength. Soluble aggregates were determined by size exclusion chromatography, light scattering, and analytical ultracentrifugation. Self-association of protein at high protein concentration was monitored by sedimentation equilibrium analysis using a preparative ultracentrifuge and a microfractionator. The viscosity of one of the monoclonal antibodies investigated is highly dependent on protein concentration, pH, and ionic strength of buffer and charged excipients. This antibody shows the highest viscosity near its pI at low ionic strength conditions. Sedimentation equilibrium analysis suggests that this antibody tends to reversibly self-associate at high protein concentration. The self-association appears to be quite weak and is not detectable by sedimentation velocity and size exclusion chromatography at low protein concentration. There are no significant differences in the amounts of non-dissociable soluble aggregates formed between low viscosity and high viscosity samples. These results suggest that the reversible multivalent self-association of this protein appears to be mediated mainly by electrostatic interactions of charged residues and results in unusually high viscosity of this monoclonal antibody in solution at low ionic strength conditions.

Mesh:

Substances:

Year:  2005        PMID: 16052543     DOI: 10.1002/jps.20347

Source DB:  PubMed          Journal:  J Pharm Sci        ISSN: 0022-3549            Impact factor:   3.534


  94 in total

1.  High-throughput analysis of concentration-dependent antibody self-association.

Authors:  Shantanu V Sule; Muppalla Sukumar; William F Weiss; Anna Marie Marcelino-Cruz; Tyler Sample; Peter M Tessier
Journal:  Biophys J       Date:  2011-10-05       Impact factor: 4.033

2.  Phase separation of an IgG1 antibody solution under a low ionic strength condition.

Authors:  Hirotaka Nishi; Makoto Miyajima; Hiroaki Nakagami; Masanori Noda; Susumu Uchiyama; Kiichi Fukui
Journal:  Pharm Res       Date:  2010-04-17       Impact factor: 4.200

3.  Antibody nanoparticle dispersions formed with mixtures of crowding molecules retain activity and in vivo bioavailability.

Authors:  Maria A Miller; Tarik A Khan; Kevin J Kaczorowski; Brian K Wilson; Aileen K Dinin; Ameya U Borwankar; Miguel A Rodrigues; Thomas M Truskett; Keith P Johnston; Jennifer A Maynard
Journal:  J Pharm Sci       Date:  2012-07-06       Impact factor: 3.534

4.  Computational tool for the early screening of monoclonal antibodies for their viscosities.

Authors:  Neeraj J Agrawal; Bernhard Helk; Sandeep Kumar; Neil Mody; Hasige A Sathish; Hardeep S Samra; Patrick M Buck; Li Li; Bernhardt L Trout
Journal:  MAbs       Date:  2015-09-23       Impact factor: 5.857

5.  Viscosity Analysis of Dual Variable Domain Immunoglobulin Protein Solutions: Role of Size, Electroviscous Effect and Protein-Protein Interactions.

Authors:  Ashlesha S Raut; Devendra S Kalonia
Journal:  Pharm Res       Date:  2015-08-19       Impact factor: 4.200

Review 6.  Molecular basis of high viscosity in concentrated antibody solutions: Strategies for high concentration drug product development.

Authors:  Dheeraj S Tomar; Sandeep Kumar; Satish K Singh; Sumit Goswami; Li Li
Journal:  MAbs       Date:  2016-01-06       Impact factor: 5.857

Review 7.  Histidine-tag-directed chromophores for tracer analyses in the analytical ultracentrifuge.

Authors:  Lance M Hellman; Chunxia Zhao; Manana Melikishvili; Xiaorong Tao; James E Hopper; Sidney W Whiteheart; Michael G Fried
Journal:  Methods       Date:  2010-12-25       Impact factor: 3.608

Review 8.  Assessment and significance of protein-protein interactions during development of protein biopharmaceuticals.

Authors:  Sandeep Yadav; Jun Liu; Thomas M Scherer; Yatin Gokarn; Barthélemy Demeule; Sonoko Kanai; James D Andya; Steven J Shire
Journal:  Biophys Rev       Date:  2013-03-14

9.  Ion-specific modulation of protein interactions: anion-induced, reversible oligomerization of a fusion protein.

Authors:  Yatin R Gokarn; R Matthew Fesinmeyer; Atul Saluja; Shawn Cao; Jane Dankberg; Andrew Goetze; Richard L Remmele; Linda O Narhi; David N Brems
Journal:  Protein Sci       Date:  2009-01       Impact factor: 6.725

10.  Resolving self-association of a therapeutic antibody by formulation optimization and molecular approaches.

Authors:  Paul Casaz; Elisabeth Boucher; Rachel Wollacott; Brian G Pierce; Rachel Rivera; Maja Sedic; Sadettin Ozturk; William D Thomas; Yang Wang
Journal:  MAbs       Date:  2014       Impact factor: 5.857

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.